ctrl K

Watchlist Price Alert

Atea Pharmaceuticals Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

2.81

-0.15 (-5.07%)

At close: May 06, 2025, 3:59 PM

2.80

-0.53%

After-hours: May 06, 2025, 04:05 PM EDT

Atea Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	351.37M	48.63M	n/a	n/a
Cost of Revenue	n/a	70.09M	260K	29K	19K	17K	17K
Gross Profit	n/a	-70.09M	-260K	351.34M	48.61M	-17K	-17K
Operating Income	-192.95M	-164.16M	-130.65M	138.38M	-11.03M	-14.61M	-9.48M
Interest Income	n/a	29.22M	11.15M	213K	83K	574K	413K
Pretax Income	-167.46M	-134.94M	-119.5M	138.59M	-10.95M	-14.03M	-9.06M
Net Income	-168.38M	-135.96M	-115.91M	121.19M	-10.86M	-13.46M	-9.06M
Selling & General & Admin	48.85M	49.92M	48.71M	45.78M	21.64M	4.44M	2.8M
Research & Development	144.1M	132.84M	81.94M	167.21M	38.02M	10.17M	6.67M
Other Expenses	n/a	-88.69M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	192.95M	94.07M	130.65M	212.99M	59.66M	14.61M	9.48M
Interest Expense	n/a	n/a	11.15M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	164.16M	130.65M	212.99M	59.66M	14.61M	9.48M
Income Tax Expense	925K	1.02M	-3.59M	17.4M	-83K	-574K	413K
Shares Outstanding (Basic)	84.26M	83.39M	83.25M	82.82M	82.44M	82.62M	47.29M
Shares Outstanding (Diluted)	84.26M	83.39M	83.25M	88.25M	82.44M	82.62M	47.29M
EPS (Basic)	-2	-1.63	-1.39	1.46	-0.13	-0.16	-0.19
EPS (Diluted)	-2	-1.63	-1.39	1.37	-0.13	-0.16	-0.19
EBITDA	-167.04M	-119.59M	-110.84M	138.41M	-11.01M	-14.59M	-9.46M
EBIT	n/a	-120.01M	-119.5M	138.38M	-11.03M	-14.61M	-9.48M
Depreciation & Amortization	n/a	416K	260K	29K	19K	17K	17K